Democritus University of Thrace (DUTH)
Μελέτη της έκφρασης της πρωτεϊνης S100 και συσχετισμός της με άλλα μοριακά μονοπάτια που συμμετέχουν στην καρκινογένεση, σε ασθενείς με μη -μικροκυτταρικό καρκίνο του πνεύμονα
Abstract
dc:descriptionRegarding S100A2 and its role in NSCLC there are conflicting published results. Feng et al showed that S100A2 expression was downregulated and on the contrary Heighway et al showed that S100A2 strongly expressed. Wang et al showed that S100A2 protein was also strongly expressed in NSCLC. The aim of this study is to analyse the nuclear, cytoplasmic expression and intensity pattern of S100A2 protein as well as to correlate this with other clinicopathologic characteristics and molecules (p53, Caspase 3, Ki-67, ERCC1, RRM1) involved in carcinogenesis, in NSCLC patients. We also analyzed their prognostic role on overall survival and disease free interval. Microarray data for 74 paraffin-embedded specimens from patients with NSCLC were immunostained for S100A2 and p53 proteins. Immunohistochemical staining patterns of S100A2 in the NSCLC tissue samples examined were either nuclear (nS100A2), cytoplasmic (cS100A2), or both. A significant association between nS100A2 positivity and better disease-free interval was observed (p=0.047). Patients without lymphatic infiltration and an earlier disease stage had significantly better overall survival and disease-free interval. The S100A2 expression pattern in operable NSCLC varies widely, and this differential expression (nuclear, cytoplasmic or both) seems to correlate with prognosis. Intensity of expression was highest in the early and advanced stages, and equally distributed in the middle stages. This is indicative for at least a dual role of this protein in carcinogenesis.ERCC1 (Excision repair cross-complementation group 1) is one crucial enzyme in the nucleotide repair process with excision. RRM1 (Ribonucleotide reductase subunit M1) has been involved in the synthesis and DNA repair and in gemcitabine metabolism. ERCC1 and RRM1 mRNAs were counted with the ΔΔCT method using b- actin as the reference gene. There were no statistical significant correlations between these genes expression, clinicopathologic parameters and overall survival or disease free interval.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Hountis, Panagiotis
- Χουντής, Παναγιώτης
Subjects
dc:subject × 20- Πρωτεΐνες S100A2
- Μη μικροκυτταρικός καρκίνος πνεύμονα
- Καρκίνος πνεύμονα
- Μοριακοί δείκτες καρκίνου πνεύμονα
- Καρκινογένεση
- Πρωτεΐνες S100
- Ανοσοϊστοχημικοί δείκτες καρκίνου πνεύμονα
- S100A2 proteins
- Non small cell lung cancer
- Lung cancer
- Molecular markers in lung cancer
- Carcinogenesis
- S100 proteins
- Immunohistochemical markers in lung cancer
- ERCC1
- RRM1
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39098